VivoSim Labs
VIVS
35 hedge funds and large institutions have $1.76M invested in VivoSim Labs in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
3,100% more call options, than puts
Call options by funds: $32K | Put options by funds: $1K
1.03% less ownership
Funds ownership: 1.79% → 0.77% (-1%)
8% less funds holding
Funds holding: 38 → 35 (-3)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
33% less capital invested
Capital invested by funds: $2.64M → $1.76M (-$883K)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$44.3K |
| 2 |
Renaissance Technologies
New York
|
+$38.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.42K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$1.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAMA
Nikko Asset Management Americas
New York
|
-$641K |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$641K |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$302K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.93K |
| 5 |
BlackRock
New York
|
-$287 |
VIVS Hedge Fund Activity: Q1 2023 in Review
35 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2023, worth a combined $1.76M — down 33% from $2.64M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VIVS and 4 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Morgan Stanley, adding an estimated $44.3K. The largest seller was Nikko Asset Management Americas, exiting entirely with an estimated $641K sold.
- 35 institutional investors held VivoSim Labs (VIVS) as of Q1 2023, down from 38 in Q4 2022.
- Funds reported $1.76M of VivoSim Labs stock for Q1 2023, down 33% quarter-over-quarter.
- 4 funds opened new VivoSim Labs positions in Q1 2023 and 7 closed out, a net change of -3 holders.
- The largest VivoSim Labs buyer in Q1 2023 was Morgan Stanley, an estimated $44.3K added.
- The largest VivoSim Labs seller in Q1 2023 was Nikko Asset Management Americas, an estimated $641K sold.
Based on aggregated 13F filings for Q1 2023.